HealthInvest Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.11M | Sell |
73,165
-3,833
| -5% | -$425K | 3.47% | 11 |
|
|
2025
Q1 | $8.63M | Buy |
+76,998
| New | +$8.63M | 3.81% | 9 |
|
|
2024
Q2 | – | Sell |
-52,000
| Closed | -$3.81M | – | 43 |
|
|
2024
Q1 | $3.81M | Sell |
52,000
-46,974
| -47% | -$3.44M | 2.32% | 17 |
|
|
2023
Q4 | $8.02M | Buy |
+98,974
| New | +$8.02M | 6.28% | 3 |
|
|
2022
Q4 | $5.22M | Sell |
60,760
-44,240
| -42% | -$3.8M | 10.07% | 6 |
|
|
2022
Q3 | $6.48M | Buy |
105,000
+47,000
| +81% | +$2.9M | 13.68% | 3 |
|
|
2022
Q2 | $3.59M | Sell |
58,000
-40,000
| -41% | -$2.47M | 8.26% | 5 |
|
|
2022
Q1 | $5.83M | Buy |
+98,000
| New | +$5.83M | 9.28% | 6 |
|
|
2017
Q4 | $2.59M | Sell |
36,100
-40,500
| -53% | -$2.9M | 5.46% | 16 |
|
|
2017
Q3 | $6.21M | Sell |
76,600
-21,000
| -22% | -$1.7M | 7.25% | 12 |
|
|
2017
Q2 | $6.91M | Sell |
97,600
-19,400
| -17% | -$1.37M | 8.61% | 6 |
|
|
2017
Q1 | $7.95M | Buy |
117,000
+4,000
| +4% | +$272K | 12.19% | 3 |
|
|
2016
Q4 | $8.09M | Buy |
+113,000
| New | +$8.09M | 7.46% | 8 |
|
|
2016
Q1 | – | Sell |
-229,300
| Closed | -$23.2M | – | 19 |
|
|
2015
Q4 | $23.2M | Sell |
229,300
-20,000
| -8% | -$2.02M | 10.92% | 3 |
|
|
2015
Q3 | $24.5M | Buy |
249,300
+9,000
| +4% | +$884K | 14.48% | 1 |
|
|
2015
Q2 | $28.1M | Buy |
240,300
+117,000
| +95% | +$13.7M | 14.37% | 2 |
|
|
2015
Q1 | $12.1M | Buy |
123,300
+29,000
| +31% | +$2.85M | 8.38% | 6 |
|
|
2014
Q4 | $8.89M | Buy |
94,300
+5,000
| +6% | +$471K | 7.35% | 10 |
|
|
2014
Q3 | $9.51M | Sell |
89,300
-29,200
| -25% | -$3.11M | 6.93% | 7 |
|
|
2014
Q2 | $9.83M | Buy |
+118,500
| New | +$9.83M | 5.53% | 10 |
|